A Study of Faricimab (RO6867461) in Participants With Center-Involving Diabetic Macular Edema
Launched by HOFFMANN-LA ROCHE · Mar 1, 2016
Trial Information
Current as of July 04, 2025
Completed
Keywords
ClinConnect Summary
No description provided
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Macular edema associated with diabetic retinopathy
- • Decreased visual acuity attributable primarily to DME
- • Diagnosis of diabetes mellitus
- Exclusion Criteria:
- • High risk proliferative diabetic retinopathy
- • Cataract surgery within 3 months of Baseline, or any other previous intraocular surgery
- • Uncontrolled glaucoma
- • Current or history of ocular disease in the study eye other than DME
- • Major illness or major surgical procedure within 1 month prior to Day 1
- • Uncontrolled blood pressure
- • Glycosylated hemoglobin (HbA1c) greater than (\>) 12 percent (%) at screening
- • Untreated diabetes mellitus or initiation of oral anti-diabetic medication or insulin within 4 months prior to Day 1
About Hoffmann La Roche
Hoffmann-La Roche, commonly known as Roche, is a global leader in biotechnology and pharmaceuticals, committed to advancing healthcare through innovative research and development. With a strong focus on oncology, immunology, infectious diseases, and central nervous system disorders, Roche leverages cutting-edge science to deliver transformative therapies and diagnostics. The company is dedicated to improving patient outcomes by conducting rigorous clinical trials and collaborating with healthcare professionals and organizations worldwide. Roche's unwavering commitment to precision medicine and personalized healthcare positions it at the forefront of the industry, driving progress in the quest for effective treatments and improved patient care.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Albuquerque, New Mexico, United States
Austin, Texas, United States
Desoto, Texas, United States
Morgantown, West Virginia, United States
Baltimore, Maryland, United States
Fort Myers, Florida, United States
Walnut Creek, California, United States
Phoenix, Arizona, United States
Augusta, Georgia, United States
Santa Barbara, California, United States
Paducah, Kentucky, United States
Lexington, Kentucky, United States
Houston, Texas, United States
Mountain View, California, United States
Edina, Minnesota, United States
Albany, New York, United States
Indianapolis, Indiana, United States
West Des Moines, Iowa, United States
Orchard Park, New York, United States
Spokane, Washington, United States
Pensacola, Florida, United States
The Woodlands, Texas, United States
Melbourne, Florida, United States
Reno, Nevada, United States
Albuquerque, New Mexico, United States
Lynbrook, New York, United States
Asheville, North Carolina, United States
Charlotte, North Carolina, United States
Portland, Oregon, United States
Abilene, Texas, United States
Fullerton, California, United States
Phoenix, Arizona, United States
Grand Rapids, Michigan, United States
Eugene, Oregon, United States
Salt Lake City, Utah, United States
Phoenix, Arizona, United States
Palm Desert, California, United States
Saint Petersburg, Florida, United States
Tallahassee, Florida, United States
Marietta, Georgia, United States
Oak Forest, Illinois, United States
Bloomfield, New Jersey, United States
Cleveland, Ohio, United States
Ladson, South Carolina, United States
Nashville, Tennessee, United States
Tucson, Arizona, United States
Poway, California, United States
Colorado Springs, Colorado, United States
Columbus, Ohio, United States
Florence, South Carolina, United States
Charlottesville, Virginia, United States
Deerfield Beach, Florida, United States
San Antonio, Texas, United States
Germantown, Tennessee, United States
Sacramento, California, United States
Inglewood, California, United States
Oceanside, California, United States
Chicago, Illinois, United States
Oak Park, Illinois, United States
Austin, Texas, United States
Patients applied
Trial Officials
Clinical Trials
Study Director
Hoffmann-La Roche
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials